Arrhythmias & EP
Conference Coverage
Apixaban provides larger medical cost savings than other NOACs
Major finding: Using apixaban instead of warfarin for stroke prevention in AF would result in an estimated medical cost savings of $1,245 per...
Conference Coverage
Patients with LBBB get bigger long-term survival bang from CRT-D
Major finding: All-cause mortality over 7 years in patients with mild heart failure, left ventricular dysfunction, and left bundle-branch block...
Guidelines
Novel anticoagulants get nod in new AF guidelines
Data source: Expert opinion.Disclosures: The work of the writing committee was supported exclusively by the ACC, AHA, and HRS without commercial...
News
Apixaban approved for preventing DVT and pulmonary embolism after hip/knee surgery
News
Warfarin beneficial after acute atrial fib–associated MI in chronic kidney disease
Major finding: Across all categories of CKD severity, patients taking warfarin had 5.8% fewer deaths, 2.2% fewer MIs, and 1.8% fewer ischemic...
News
Physician/patient communication on ICDs deemed problematic
News
Post-LVAD acute kidney injury is predictor of all-cause mortality
Major finding: Acute kidney injury was a significant predictor of 30-day mortality (hazard ratio, 3.01; P = .03) in patients who had implantation...
Guidelines
AAN issues nonvalvular atrial fibrillation stroke prevention guideline
Conference Coverage
VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?
News
Continuous AF monitors raise questions about when to intervene
Major finding: After 6 months, Medtronic’s Reveal XT heart monitor implant detected atrial fibrillation in 19 patients (8.6%).
News
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
Major finding: Recurrence of any atrial tachyarrhythmia lasting longer than 30 seconds was documented in 36 patients in the ablation group (54.5...